Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Gracevit

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Sitafloxacin (STFX, Gracevit 50 mg, fine granules 10%), an oral quinolone antibacterial agent, was approved additionally for… Expand
Is this relevant?
Review
2012
Review
2012
Sitafloxacin (STFX, Gracevit 50mg, fine granules 10%), a new quinolone antibacterial agent, was approved in January 2008, and the… Expand
Is this relevant?
Review
2011
Review
2011
Sitafloxacin (STFX, Gracevit 50 mg, fine granules 10%), a new quinolone antibacterial agent, was approved in January 2008, and… Expand
Is this relevant?
2008
2008
 
Is this relevant?
Review
2008
Review
2008
Sitafloxacin hydrate (DU-6859a, Gracevit), a new-generation, broad-spectrum oral fluoroquinolone that is very active against many… Expand
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
  • Corpus ID: 31278248
 
Is this relevant?